This conspicuous expression pattern was confirmed in an additional dataset with pediatric BCP-ALL patients (Figure S3), corresponded to the cell line data (Figure 1A), and indicates both aberrant activation of NKX6-3 and its regulatory connection with fusion gene TCF3::PBX1. This evidence concerns the gene NKX6-3 and acute lymphoblastic leukemia.